Trial of Active Immunotherapy With Globo H-KLH (OPT-822) in Metastatic Breast Cancer Subjects
This study is currently recruiting participants.
Verified July 2012 by OBI Pharma, Inc
Sponsor:
OBI Pharma, Inc
Information provided by (Responsible Party):
OBI Pharma, Inc
ClinicalTrials.gov Identifier:
NCT01516307
First received: January 19, 2012
Last updated: June 12, 2013
Last verified: July 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | December 2016 |
| Estimated Primary Completion Date: | December 2013 (Final data collection date for primary outcome measure) |